Nuvation Bio Inc.
ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS
Last updated:
Abstract:
The disclosure relates to anti-cancer compounds derived from nuclear steroid receptor binders, to products containing the same, as well as to methods of their use and preparation.
Status:
Application
Type:
Utility
Filling date:
12 Nov 2020
Issue date:
15 Jul 2021